Publication | Closed Access

O-271 Phase II randomized study of pemetrexed plus carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

MedicineMetronomic TherapyPathologyBronchial NeoplasmFront-line ChemotherapyCancer TreatmentO-271 Phase IiOncologyRadiation OncologyLung Cancer